‘Precision Health: Population health data science’ is a Barts Life Sciences research programme, co-led by Queen Mary’s Clinical Effectiveness Group (CEG) and Barts Cancer Institute – Centre for Cancer Biomarkers and Biotherapeutics. The research has initial funding of £5.7m from Barts Charity to develop new ways of using health data for the benefit of patients and the public.
Our researchers are analysing data from the patient health records held by GP practices and hospitals, and data derived from tissue samples, imaging and genomics. We are studying disease risk factors and outcomes on a population scale to find new ways of preventing, diagnosing and managing chronic diseases in people who share the same characteristics. The long-term aim is to improve population health equity by enabling clinicians to tailor their approaches for specific patient groups.
Join us for examples of research excellence in health data science from across the Wolfson Institute of Population Health, Barts Cancer Institute, Queen Mary, Barts Health, and more widely.
The programme has trusted access to national and local health data sets, including primary and secondary care data from North East London - one of the most ethnically diverse and economically disadvantaged NHS regions in the UK. We are using pseudonymised phenotypic data (which includes patient demographics and symptoms as recorded in the patient health record) and biological data (derived from tissue samples, scans and genomics).
Programme leads: Professor Carol Dezateux, Dr John Robson (Clinical Effectiveness Group). Professor Claude Chelala, Professor Louise Jones (Barts Cancer Institute).
Programme Manager: Mary Thomas